Outcome Analysis of Phase I Trial Patients With Metastatic KRAS and/or TP53 Mutant Non-Small Cell Lung Cancer
Oncotarget - United States
doi 10.18632/oncotarget.25947
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2018
Authors
Publisher
Impact Journals, LLC